|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
For other uses, see Receptor.
In biochemistry, a receptor is a protein molecule, embedded in either the plasma membrane or cytoplasm of a cell, to which a mobile signaling (or "signal") molecule may attach. A molecule which binds to a receptor is called a "ligand," and may be a peptide (such as a neurotransmitter), a hormone, a pharmaceutical drug, or a toxin, and when such binding occurs, the receptor goes into a conformational change which ordinarily initiates a cellular response. However, some ligands merely block receptors without inducing any response (e.g. antagonists). Ligand-induced changes in receptors result in physiological changes which constitute the biological activity of the ligands.
OverviewThe shapes and actions of receptors are studied by X-ray crystallography and computer modelling, which have advanced the understanding of drug action at the binding sites of receptors. Depending on their functions and ligands, several types of receptors may be identified:
Binding and activationLigand binding is an equilibrium process. Ligands bind to receptors and dissociate from them according to the law of mass action.
One measure of how well a molecule fits a receptor is the binding affinity, which is inversely related to the dissociation constant Kd. A good fit corresponds with high affinity and low Kd. The final biological response (e.g. second messenger cascade or muscle contraction), is only achieved after a significant number of receptors are activated. If the receptor exists in two states (see this picture), then the ligand binding must account for these two receptor states. For a more detailed discussion of two-state binding, which is thought to occur as an activation mechanism in many receptors see this link. Constitutive activityA receptor which is capable of producing its biological response in the absence of a bound ligand is said to display "constitutive activity." 1 The constitutive activity of receptors may be blocked by inverse agonist binding. Mutations in receptors that result in increased constitutive activity underlie some inherited diseases, such as precocious puberty (due to mutations in luteinizing hormone receptors) and hyperthyroidism (due to mutations in thyroid-stimulating hormone receptors). Psychostimulants act as inverse agonists on dopamine receptors. For the use of statistical mechanics in a quantitative study of the ligand-receptor binding affinity, see the comprehensive article2 on the configuration integral. Agonists versus antagonistsNot every ligand that binds to a receptor also activates the receptor. The following classes of ligands exist:
Peripheral membrane protein receptors
Transmembrane receptorsMetabotropic receptorsG protein-coupled receptorsThese receptors are also known as seven transmembrane receptors or 7TM receptors, because they pass through the membrane seven times.
Receptor tyrosine kinasesThese receptors detect ligands and propagate signals via the tyrosine kinase of their intracellular domains. This family of receptors includes;
Guanylyl cyclase receptors
Ionotropic receptorsIonotropic receptors are heteromeric or homomeric oligomers 3. They are receptors that respond to extracellular ligands and receptors that respond to intracellular ligands. Extracellular ligands
Intracellular ligands
The entire repertoire of human plasma membrane receptors is listed at the Human Plasma Membrane Receptome (http://www.receptome.org). Intracellular receptorsTranscription factorsVarious
Role in Genetic DisordersMany genetic disorders involve hereditary defects in receptor genes. Often, it is hard to determine whether the receptor is nonfunctional or the hormone is produced at decreased level; this gives rise to the "pseudo-hypo-" group of endocrine disorders, where there appears to be a decreased hormonal level while in fact it is the receptor that is not responding sufficiently to the hormone. Receptor RegulationCells can increase (upregulate) or decrease (downregulate) the number of receptors to a given hormone or neurotransmitter to alter its sensitivity to this molecule. This is a locally acting feedback mechanism.
Ligand-bound desensitation Vol. 135. No. 5 2130-2136</ref>
In immune systemThe main receptors in the immune system are pattern recognition receptors (PRRs), Toll-like receptors (TLRs), killer activated and killer inhibitor receptors (KARs and KIRs), complement receptors, Fc receptors, B cell receptors and T cell receptors. 6
See also
External links
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Strona • Strona • |